We previously found that a form of EpsteinBarr virus with rearranged DNA induces replication of latent Epstein-Barr virus. We now have found that one of three fragments of this rearranged DNA, when cloned in recombinant plasmids and used to transfect cells, can activate expression of several polypeptides from a latent viral genome. The 33-kDa protein that is the product of the active fragment is likely to be responsible for disruption of latency.
The biochemical mechanisms that maintain latency and that are modulated upon reactivation are not understood. Excellent experimental models exist for establishment and maintenance of herpes simplex latency in ganglionic neurons of the mouse, but it is difficult to carry out biochemical analysis in vivo (2) . Progress has been made in development of in vitro models of herpes simplex latency in human fibroblasts and, recently, in neuronal cultures (3) . However, viral replication must be suppressed by addition of interferon and inhibitors of viral DNA synthesis; furthermore, only some of the cultured cells contain viral genomes (4) .
Latency of the Epstein-Barr herpesvirus (EBV) in human B lymphocytes can be established, manipulated, and analyzed in cell culture. A few viral functions are expressed during latency, but mature transcripts of genes representing products made when virus is synthesized are not present. EBV latency can be activated by a number of diverse stimuli, including phorbol ester tumor promoters, butyrate, antiimmunoglobulins, and a factor in serum (5) (6) (7) (8) . Induction of viral replication is accompanied by synthesis of many new mRNAs and polypeptides (9) .
Findings in a series of recent experiments indicated that a form of rearranged EBV DNA, which we call heterogeneous or het DNA, might provide clues about viral genes and gene products that play a role in latency of EBV. het DNA was found in a cell line designated P3J-HR-1 (HR-1) which spontaneously synthesizes considerable amounts of EBV. It was initially found that het DNA was not associated with all HR-1 cells; cellular subclones of HR-1 cells lacking het DNA could readily be isolated. Those cell clones which lacked het DNA spontaneously synthesized small amounts of virus, although much more virus could be recovered after induction with phorbol ester (10) . Virus released from HR-1 cells did not immortalize lymphocytes, a defect which correlated with a sizeable genomic deletion (11) . Instead, HR-1 virus is measured by its capacity to induce early antigens (EA) in Raji cells, which already contain an EBV genome. Subcloned HR-1 virus without het DNA did not cause EA expression in Raji cells. A rare HR-1 subclone with large amounts of het DNA spontaneously released virus that caused EA expression in Raji cells (12) . Thus spontaneous virus production, the ability to induce EA in Raji cells, and the presence of het DNA are linked.
In further experiments, viral populations containing only standard HR-1 DNA were compared with those harboring both standard and het DNA for their ability to induce expression of a latent EBV with an immortalizing phenotype. Only virus stocks containing het DNA activated a latent genome in trans (13) .
het DNA has the structural properties of defective viral DNA, although its biotype is activating rather than interfering. The genome is extensively rearranged and portions of it are repeated (14) . Included in the het DNA we have been studying is a 16-kilobase-pair (kbp) palindrome (unpublished observation). We have now asked whether we could identify, within het DNA, specific regions that are responsible for the disruption of latency.
MATERIALS AND METHODS
Viral het DNA Fragments. The virions of P3J-HR-1 HH543-5 (clone 5) contain, in addition to standard HR-1 DNA, four novel BamHI heterogeneous (het) restriction fragments. The sizes of these four het fragments are 7.5, 7.0, 2.8, and 1.8 kbp. The 7.5-kbp het fragment is homologous to BamHI fragment C (Chet), and the 1.8-kbp fragment is homologous to BamHI fragment S (Shet). Both of these appear to represent standard fragments from which deletions have occurred. The other two het fragments are homologous to BamHI fragments that are not contiguous on the genome. The 7.0-kbp het fragment is homologous to standard BamHI fragments M and B' (MB'het); the 2.8-kbp het DNA fragment is homologous to BamHI fragments W and Z (WZhet) (13) . DNA was isolated from clone 5 virions and the four novel BamHI fragments were cloned in pBR322 and pSV2neo (15 (17) . They express the EBV nuclear antigen (EBNA), a product of the latent cycle, but only a rare cell makes antigens of the viral replicative cycle. D98/HR-1 cells are readily transfectable by the calcium phosphate method (18) . Mouse LTK-(thymidine kinase minus) cells, obtained from W. Summers (Yale University), were maintained in Eagle's minimal essential medium containing antibiotics and 5-10% fetal bovine serum. To induce the replicative cycle in D98/HR-1 cells, phorbol 12-myristate 13-acetate (PMA) was used at 20 ng/ml for 72 hr. Cloned het viral DNA (4-6 gg) was introduced into confluent cultures on coverslips in 60-mm dishes by the calcium phosphate precipitation method (19) . To obtain stable transformants, D98/HR-1 cells were transfected with either pSV2neo or pSV2neo-WZhet DNA. The neomycin analog G418 (geneticin) was introduced, at a concentration of 400 ,ug/ml in medium, 72 hr after transfection. Cells were maintained in selective media at all times. Seven weeks after initial selection, cells were analyzed for antigen production.
Antigen Expression. At intervals after transfection, the coverslips were removed, washed twice in phosphate-buffered saline, and fixed for 10 min in acetone/methanol (2:1, vol/vol) or acetone alone. Coverslips were stored at -20°C until reacted with either polyvalent sera or mouse monoclonal antibodies. Monoclonal antibodies R3.3 and K8.1, against the diffuse (EA-D) and restricted (EA-R) components of EA, and L.2, against viral capsid antigen (VCA), were obtained from G. Pearson (20) . A fourth monoclonal antibody, 72A1, specific for membrane antigen (MA), was from G. Hoffman (21) . The appropriate fluorescein-conjugated anti-human or anti-mouse antisera were purchased.
Immunoblots. Cells were transfected in 100-mm dishes with 12 ,g of cloned het DNA. Transfected cells were scraped into 0.5 ml of NaDodSO4 sample buffer (0.1% 2-mercaptoethanol/10% (vol/vol) glycerol/2% NaDodSO4/ 0.1% bromophenol blue/625 mM Tris Cl, pH 6.8) either 72 hr (LTK-cells) or 24-36 hr (D98/HR-1 cells) after transfection and boiled for 10 min. Approximately one-third of each total sample was subjected to NaDodSO4/10% PAGE. Protein transfer and detection of the antigen-antibody complex on the filter were as described (22) .
RESULTS

Antigen Expression After Gene Transfer with Cloned het
Fragments in Cells Without an EBV Genome. To determine whether het DNA encoded any antigenic proteins, the three het fragments cloned in pSV2neo were introduced into LTKmouse cells and HeLa cells. After 72 hr, antigens were sought by indirect immunofluorescence with a polyvalent human serum, W.C., which reacts with a large number of replicative proteins (23) . In the mouse and HeLa cells, MB'het and WZhet expressed antigens that were restricted to the nucleus ( Fig. 1 B and D and data not shown) . The Shet fragment did not induce any antigen in the LTK-or HeLa cells.
Antigen Expression After Gene Transfer with Cloned het
Fragments in Cells Containing an EBV Genome. We next asked whether any differences in antigen expression could be seen when the het fragments were transfected into a background containing a latent genome. The same three het fragments cloned in pSV2neo were therefore introduced into D98/HR-1, a hybrid cell which contains latent HR-1 genomes. Again, WZhet and MB'het caused appearance of antigens detected by the polyvalent human serum, and Shet was without effect. However, the antigen seen after introduction of pSV2neo-WZhet into D98/HR-1 cells was not exclusively nuclear but was observed in cytoplasm in most of the cells (Fig. 1C) . pSV2neo-MB'het, which induced a prominent nuclear antigen in many mouse and HeLa cells, now induced a rare, fainter nuclear antigen in D98/HR-1 cells ( Fig. 1 A and  B) . As shown in Table 1 Proc (Fig. 3) . Immunoblotting was used to identify protein(s) made following gene transfer with pSV2neo-WZhet. A single 33-kDa protein was made after introduction of pSV2neo-WZhet into LTK-cells. A similar sized protein is synthesized in COS-1 cells (unpublished data). No such protein was seen in cells transfected with pSV2neo alone. However, after gene transfer of pSV2-neo-WZhet into D98/HR-1 cells, at least six new viral polypeptides, ranging in size between 35 and 60 kDa, were identified. These polypeptides were absent from D98/HR-1 cells that had been transfected only with pSV2neo. The pattern of polypeptides made in D98/HR-1 cells after addition of pSV2neo-WZhet was similar to that seen after treatment of the cells with the phorbol ester PMA, which also induces viral replication (5) . Against the background of induced viral polypeptides, it was difficult to tell whether the 33-kDa polypeptide that was found in LTK-cells was also made in D98/HR-1 cells.
Since the pSV2neo plasmid carries a drug-resistance marker, we obtained a population of D98/HR-1 cells resistant to G418 after transfection with either pSV2neo or pSV2neo-WZhet. Those D98/HR-1 cells containing the latter plasmid again expressed a group of viral polypeptides, the pattern of which was similar to that seen transiently after transfection. A polypeptide of about 41 kDa, which was observed in the transient transfection of D98/HR-1 cells with pSV2neo-WZhet, was missing in the corresponding drug-resistant transformants. About 6 weeks after preparation of the samples represented in Fig. 3B , the drug-resistant D98/HR-1 cells spontaneously stopped making viral antigens.
Antigen Expression After Introduction of WZhet DNA and Two Subfragments in Vector pSVOd. Indirect evidence suggested that expression of a protein encoded by WZhet was responsible for activation of latency. The WZhet fragment in the pSV2neo vector always caused more cells to express antigen than did the same het fragment when inserted into pBR322 (Table 1) or pSVOd ( Table 4) . Neither of the latter plasmids markedly enhance eukaryotic gene transcription (23) . To determine whether the entire 2.8-kbp WZhet fragment was required for the interruption of latency, the WZhet fragment was digested at its single HindlI site and the two subfragments, one of 1.8-kbp and the other of 1.0-kbp, were subcloned, as BamHI-HindIII subfragments, in pSVOd. These constructs and the entire WZhet fragment cloned in pSVOd were used to transfect LTK-and D98/HR-1 cells. Neither subfragment induced antigens in LTK-or D98/HR-1 cells, whereas the full-sized WZhet fragment inserted into pSVOd induced antigen in both systems (Table 4 and data not shown). Once again the observed antigen was nuclear in the LTK-cells and predominantly cytoplasmic in the D98/HR-1 cells. These data are consistent with the idea that interruption of the WZhet fragment eliminates the nuclear antigen and that this encoded protein is required for the activation of latency.
DISCUSSION
We have analyzed the mechanism of herpesvirus latency with the powerful techniques of molecular genetics. Our results show that expression of latent EBV can be activated by gene transfer of a 2.8-kbp fragment of rearranged het DNA.
Virion populations that contain a mixture of standard and het DNA activate viral DNA replication, antigen expression, and virion synthesis in cells containing latent EBV (12, 13, 24 containing latent EBV, many new polypeptides are induced (Fig. 3) . We have not yet determined whether introduction of WZhet leads to synthesis of mature virions from D98/HR-1 cells. Virion production takes place at low frequency and would best be detected by bioassay. However, there is no bioassay for virions in the D98/HR-1 cells. The genomes are nonimmortalizing and, since they lack het DNA, they do not induce EA in Raji cells.
Mechanism of Induction. Our data do not indicate the level at which latency is regulated. The principal difference between lymphoid cells that have a latent genome and those whose genome is replicating is in the number of different mRNAs they contain (9) . However, there is also evidence that more nuclear viral RNAs are found than appear as mature cytoplasmic mRNAs (26) . Thus WZhet probably activates transcription, but it might also affect posttranscriptional processing and/or transport.
The results pose a number of questions about how WZhet might activate expression. What is the importance of the rearrangement in het DNA? It is likely that this rearrangement is required, since standard HR-1 virions with unrearranged DNA do not disrupt latency (13) . Are transcription and a product from WZhet required to activate latency, or is the DNA alone sufficient? Induction occurred at a low level when WZhet cloned in pBR322 or in pSVOd was used, but the signal was considerably weaker than when the fragment was introduced into the pSV2neo vector (Tables 1 and 4) . Only the latter plasmid contains a complete set of "enhancer" sequences, which appear to be needed to produce the phenomenon. In het virions, these enhancers may be provided by sequences outside of WZhet. pSV2neo-WZhet interrupted by the restriction endonuclease EcoRI, which does not cleave the WZhet DNA but cuts the vector, was unable to activate expression in a transient assay (data not shown). Thus, the DNA itself is probably not active (e.g., by binding an inhibitory molecule).
The results suggest that the 33-kDa protein encoded by WZhet is responsible for activation of the latent genome. This protein shares antigenic epitopes with a "standard" EBV polypeptide, since human sera with antibody to EBV react with it. However, we do not know whether an identical polypeptide is made during the course of the normal replicative cycle. The 33-kDa protein may also be a novel viral fusion protein that results from the juxtaposition of two nonadjacent coding regions. Whether the WZhet product directly activates transcription of one or more viral genes or alters an inhibitor encoded by the virus or by the cell is a problem for the future.
